LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 470

Search options

  1. Article ; Online: Improved search for a Higgs boson produced in association with Z → l+ l- in pp collisions sqrt[s] = 1.96 TeV.

    Aaltonen, T / González, B Alvarez / Amerio, S / Amidei, D / Anastassov, A / Annovi, A / Antos, J / Apollinari, G / Appel, J A / Apresyan, A / Arisawa, T / Artikov, A / Asaadi, J / Ashmanskas, W / Auerbach, B / Aurisano, A / Azfar, F / Badgett, W / Barbaro-Galtieri, A /
    Barnes, V E / Barnett, B A / Barria, P / Bartos, P / Bauce, M / Bauer, G / Bedeschi, F / Beecher, D / Behari, S / Bellettini, G / Bellinger, J / Benjamin, D / Beretvas, A / Bhatti, A / Binkley, M / Bisello, D / Bizjak, I / Bland, K R / Blocker, C / Blumenfeld, B / Bocci, A / Bodek, A / Bortoletto, D / Boudreau, J / Boveia, A / Brau, B / Brigliadori, L / Brisuda, A / Bromberg, C / Brucken, E / Bucciantonio, M / Budagov, J / Budd, H S / Budd, S / Burkett, K / Busetto, G / Bussey, P / Buzatu, A / Cabrera, S / Calancha, C / Camarda, S / Campanelli, M / Campbell, M / Canelli, F / Canepa, A / Carls, B / Carlsmith, D / Carosi, R / Carrillo, S / Carron, S / Casal, B / Casarsa, M / Castro, A / Catastini, P / Cauz, D / Cavaliere, V / Cavalli-Sforza, M / Cerri, A / Cerrito, L / Chen, Y C / Chertok, M / Chiarelli, G / Chlachidze, G / Chlebana, F / Cho, K / Chokheli, D / Chou, J P / Chung, W H / Chung, Y S / Ciobanu, C I / Ciocci, M A / Clark, A / Clark, D / Compostella, G / Convery, M E / Conway, J / Corbo, M / Cordelli, M / Cox, C A / Cox, D J / Crescioli, F / Almenar, C Cuenca / Cuevas, J / Culbertson, R / Dagenhart, D / d'Ascenzo, N / Datta, M / de Barbaro, P / De Cecco, S / De Lorenzo, G / Dell'Orso, M / Deluca, C / Demortier, L / Deng, J / Deninno, M / Devoto, F / d'Errico, M / Di Canto, A / Di Ruzza, B / Dittmann, J R / D'Onofrio, M / Donati, S / Dong, P / Dorigo, T / Ebina, K / Elagin, A / Eppig, A / Erbacher, R / Errede, D / Errede, S / Ershaidat, N / Eusebi, R / Fang, H C / Farrington, S / Feindt, M / Fernandez, J P / Ferrazza, C / Field, R / Flanagan, G / Forrest, R / Frank, M J / Franklin, M / Freeman, J C / Furic, I / Gallinaro, M / Galyardt, J / Garcia, J E / Garfinkel, A F / Garosi, P / Gerberich, H / Gerchtein, E / Giagu, S / Giakoumopoulou, V / Giannetti, P / Gibson, K / Ginsburg, C M / Giokaris, N / Giromini, P / Giunta, M / Giurgiu, G / Glagolev, V / Glenzinski, D / Gold, M / Goldin, D / Goldschmidt, N / Golossanov, A / Gomez, G / Gomez-Ceballos, G / Goncharov, M / González, O / Gorelov, I / Goshaw, A T / Goulianos, K / Gresele, A / Grinstein, S / Grosso-Pilcher, C / da Costa, J Guimaraes / Gunay-Unalan, Z / Haber, C / Hahn, S R / Halkiadakis, E / Hamaguchi, A / Han, J Y / Happacher, F / Hara, K / Hare, D / Hare, M / Harr, R F / Hatakeyama, K / Hays, C / Heck, M / Heinrich, J / Herndon, M / Hewamanage, S / Hidas, D / Hocker, A / Hopkins, W / Horn, D / Hou, S / Hughes, R E / Hurwitz, M / Husemann, U / Hussain, N / Hussein, M / Huston, J / Introzzi, G / Iori, M / Ivanov, A / James, E / Jang, D / Jayatilaka, B / Jeon, E J / Jha, M K / Jindariani, S / Johnson, W / Jones, M / Joo, K K / Jun, S Y / Junk, T R / Kamon, T / Karchin, P E / Kato, Y / Ketchum, W / Keung, J / Khotilovich, V / Kilminster, B / Kim, D H / Kim, H S / Kim, H W / Kim, J E / Kim, M J / Kim, S B / Kim, S H / Kim, Y K / Kimura, N / Klimenko, S / Kondo, K / Kong, D J / Konigsberg, J / Korytov, A / Kotwal, A V / Kreps, M / Kroll, J / Krop, D / Krumnack, N / Kruse, M / Krutelyov, V / Kuhr, T / Kurata, M / Kwang, S / Laasanen, A T / Lami, S / Lammel, S / Lancaster, M / Lander, R L / Lannon, K / Lath, A / Latino, G / Lazzizzera, I / Lecompte, T / Lee, E / Lee, H S / Lee, J S / Lee, S W / Leo, S / Leone, S / Lewis, J D / Lin, C-J / Linacre, J / Lindgren, M / Lipeles, E / Lister, A / Litvintsev, D O / Liu, C / Liu, Q / Liu, T / Lockwitz, S / Lockyer, N S / Loginov, A / Lucchesi, D / Lueck, J / Lujan, P / Lukens, P / Lungu, G / Lys, J / Lysak, R / Madrak, R / Maeshima, K / Makhoul, K / Maksimovic, P / Malik, S / Manca, G / Manousakis-Katsikakis, A / Margaroli, F / Marino, C / Martínez, M / Martínez-Ballarín, R / Mastrandrea, P / Mathis, M / Mattson, M E / Mazzanti, P / McFarland, K S / McIntyre, P / McNulty, R / Mehta, A / Mehtala, P / Menzione, A / Mesropian, C / Miao, T / Mietlicki, D / Mitra, A / Miyake, H / Moed, S / Moggi, N / Mondragon, M N / Moon, C S / Moore, R / Morello, M J / Morlock, J / Fernandez, P Movilla / Mukherjee, A / Muller, Th / Murat, P / Mussini, M / Nachtman, J / Nagai, Y / Naganoma, J / Nakano, I / Napier, A / Nett, J / Neu, C / Neubauer, M S / Nielsen, J / Nodulman, L / Norniella, O / Nurse, E / Oakes, L / Oh, S H / Oh, Y D / Oksuzian, I / Okusawa, T / Orava, R / Ortolan, L / Griso, S Pagan / Pagliarone, C / Palencia, E / Papadimitriou, V / Paramonov, A A / Patrick, J / Pauletta, G / Paulini, M / Paus, C / Pellett, D E / Penzo, A / Phillips, T J / Piacentino, G / Pianori, E / Pilot, J / Pitts, K / Plager, C / Pondrom, L / Potamianos, K / Poukhov, O / Prokoshin, F / Pronko, A / Ptohos, F / Pueschel, E / Punzi, G / Pursley, J / Rahaman, A / Ramakrishnan, V / Ranjan, N / Redondo, I / Renton, P / Rescigno, M / Rimondi, F / Ristori, L / Robson, A / Rodrigo, T / Rodriguez, T / Rogers, E / Rolli, S / Roser, R / Rossi, M / Ruffini, F / Ruiz, A / Russ, J / Rusu, V / Safonov, A / Sakumoto, W K / Santi, L / Sartori, L / Sato, K / Saveliev, V / Savoy-Navarro, A / Schlabach, P / Schmidt, A / Schmidt, E E / Schmidt, M P / Schmitt, M / Schwarz, T / Scodellaro, L / Scribano, A / Scuri, F / Sedov, A / Seidel, S / Seiya, Y / Semenov, A / Sforza, F / Sfyrla, A / Shalhout, S Z / Shears, T / Shekhar, R / Shepard, P F / Shimojima, M / Shiraishi, S / Shochet, M / Shreyber, I / Simonenko, A / Sinervo, P / Sissakian, A / Sliwa, K / Smith, J R / Snider, F D / Soha, A / Somalwar, S / Sorin, V / Squillacioti, P / Stanitzki, M / St Denis, R / Stelzer, B / Stelzer-Chilton, O / Stentz, D / Strologas, J / Strycker, G L / Sudo, Y / Sukhanov, A / Suslov, I / Takemasa, K / Takeuchi, Y / Tang, J / Tecchio, M / Teng, P K / Thom, J / Thome, J / Thompson, G A / Thomson, E / Ttito-Guzmán, P / Tkaczyk, S / Toback, D / Tokar, S / Tollefson, K / Tomura, T / Tonelli, D / Torre, S / Torretta, D / Totaro, P / Trovato, M / Tu, Y / Turini, N / Ukegawa, F / Uozumi, S / Varganov, A / Vataga, E / Vázquez, F / Velev, G / Vellidis, C / Vidal, M / Vila, I / Vilar, R / Vogel, M / Volpi, G / Wagner, P / Wagner, R L / Wakisaka, T / Wallny, R / Wang, S M / Warburton, A / Waters, D / Weinberger, M / Wester, W C / Whitehouse, B / Whiteson, D / Wicklund, A B / Wicklund, E / Wilbur, S / Wick, F / Williams, H H / Wilson, J S / Wilson, P / Winer, B L / Wittich, P / Wolbers, S / Wolfe, H / Wright, T / Wu, X / Wu, Z / Yamamoto, K / Yamaoka, J / Yang, T / Yang, U K / Yang, Y C / Yao, W-M / Yeh, G P / Yi, K / Yoh, J / Yorita, K / Yoshida, T / Yu, G B / Yu, I / Yu, S S / Yun, J C / Zanetti, A / Zeng, Y / Zucchelli, S

    Physical review letters

    2010  Volume 105, Issue 25, Page(s) 251802

    Abstract: We search for the standard model Higgs boson produced with a Z boson in 4.1 fb(-1) of integrated luminosity collected with the CDF II detector at the Tevatron. In events consistent with the decay of the Higgs boson to a bottom-quark pair and the Z boson ... ...

    Abstract We search for the standard model Higgs boson produced with a Z boson in 4.1 fb(-1) of integrated luminosity collected with the CDF II detector at the Tevatron. In events consistent with the decay of the Higgs boson to a bottom-quark pair and the Z boson to electrons or muons, we set 95% credibility level upper limits on the ZH production cross section multiplied by the H → bb branching ratio. Improved analysis methods enhance signal sensitivity by 20% relative to previous searches. At a Higgs boson mass of 115 GeV/c2 we set a limit of 5.9 times the standard model cross section.
    Language English
    Publishing date 2010-12-17
    Publishing country United States
    Document type Journal Article
    ZDB-ID 208853-8
    ISSN 1079-7114 ; 0031-9007
    ISSN (online) 1079-7114
    ISSN 0031-9007
    DOI 10.1103/PhysRevLett.105.251802
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Acute pancreatitis as a complication of acute COVID-19 in kidney transplant recipients.

    Basic-Jukic, Nikolina / Juric, Ivana / Katalinic, Lea / Furic-Cunko, Vesna / Sesa, Vibor / Mrzljak, Anna

    World journal of clinical cases

    2024  Volume 12, Issue 6, Page(s) 1104–1110

    Abstract: Background: Acute pancreatitis is a rare extrapulmonary manifestation of coronavirus disease 2019 (COVID-19) but its full correlation with COVID-19 infection remains unknown.: Aim: To identify acute pancreatitis' occurrence, clinical presentation and ...

    Abstract Background: Acute pancreatitis is a rare extrapulmonary manifestation of coronavirus disease 2019 (COVID-19) but its full correlation with COVID-19 infection remains unknown.
    Aim: To identify acute pancreatitis' occurrence, clinical presentation and outcomes in a cohort of kidney transplant recipients with acute COVID-19.
    Methods: A retrospective observational single-centre cohort study from a transplant centre in Croatia for all adult renal transplant recipients with a functioning kidney allograft between March 2020 and August 2022 to record cases of acute pancreatitis during acute COVID-19. Data were obtained from hospital electronic medical records. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was proven by a positive SARS-CoV-2 real-time reverse transcriptase-polymerase chain reaction on the nasopharyngeal swab.
    Results: Four hundred and eight out of 1432 (28.49%) patients who received a renal allograft developed COVID-19 disease. The analyzed cohort included 321 patients (57% males). One hundred and fifty patients (46.7%) received at least one dose of the anti-SARS-CoV-2 vaccine before the infection. One hundred twenty-five (39.1%) patients required hospitalization, 141 (44.1%) developed pneumonia and four patients (1.3%) required mechanical ventilation. Treatment included immunosuppression modification in 233 patients (77.1%) and remdesivir in 53 patients (16.6%), besides the other supportive measures. In the study cohort, only one transplant recipient (0.3%) developed acute pancreatitis during acute COVID-19, presenting with abdominal pain and significantly elevated pancreatic enzymes. She survived without complications with a stable kidney allograft function.
    Conclusion: Although rare, acute pancreatitis may complicate the course of acute COVID-19 in kidney transplant recipients. The mechanism of injury to the pancreas and its correlation with the severity of the COVID-19 infection in kidney transplant recipients warrants further research.
    Language English
    Publishing date 2024-03-07
    Publishing country United States
    Document type Journal Article
    ISSN 2307-8960
    ISSN 2307-8960
    DOI 10.12998/wjcc.v12.i6.1104
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The first experience with the use of dapagliflozin in combination with ACEi for treatment of IgA nephropathy after kidney transplantation.

    Basic-Jukic, Nikolina / Juric, Ivana / Furic-Cunko, Vesna / Katalinic, Lea

    International urology and nephrology

    2023  Volume 56, Issue 2, Page(s) 811–812

    MeSH term(s) Humans ; Glomerulonephritis, IGA/drug therapy ; Kidney Transplantation/adverse effects ; Glucosides/therapeutic use ; Benzhydryl Compounds/therapeutic use ; Recurrence ; Kidney
    Chemical Substances dapagliflozin (1ULL0QJ8UC) ; Glucosides ; Benzhydryl Compounds
    Language English
    Publishing date 2023-07-15
    Publishing country Netherlands
    Document type Letter
    ZDB-ID 204048-7
    ISSN 1573-2584 ; 0301-1623 ; 0042-1162
    ISSN (online) 1573-2584
    ISSN 0301-1623 ; 0042-1162
    DOI 10.1007/s11255-023-03711-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A balancing act: PHLPP2 fine tunes AKT activity and MYC stability in prostate cancer.

    Toivanen, Roxanne / Furic, Luc

    The Journal of cell biology

    2019  Volume 218, Issue 6, Page(s) 1771–1772

    Abstract: PTEN loss stimulates prostate tumor progression by sustaining AKT activation. Nowak et al. (2019. ...

    Abstract PTEN loss stimulates prostate tumor progression by sustaining AKT activation. Nowak et al. (2019.
    MeSH term(s) Disease Progression ; Humans ; Male ; PTEN Phosphohydrolase ; Phosphoprotein Phosphatases ; Prostatic Neoplasms ; Proto-Oncogene Proteins c-akt ; Signal Transduction
    Chemical Substances Proto-Oncogene Proteins c-akt (EC 2.7.11.1) ; PHLPP2 protein, human (EC 3.1.3.16) ; Phosphoprotein Phosphatases (EC 3.1.3.16) ; PTEN Phosphohydrolase (EC 3.1.3.67)
    Language English
    Publishing date 2019-05-15
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 218154-x
    ISSN 1540-8140 ; 0021-9525
    ISSN (online) 1540-8140
    ISSN 0021-9525
    DOI 10.1083/jcb.201904119
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Successful Kidney Transplantation From A Donor With Inherited Thrombophilia: A Case Report.

    Juric, Ivana / Furic-Cunko, Vesna / Katalinic, Lea / Basic-Jukic, Nikolina

    Transplantation proceedings

    2022  Volume 54, Issue 6, Page(s) 1609–1611

    Abstract: Inherited thrombophilia is a blood clotting disorder caused by genetic mutations of specific coagulation plasma factors. It is a well-established predisposing factor for venous as well as arterial thromboembolism. Thromboembolic events with renal ... ...

    Abstract Inherited thrombophilia is a blood clotting disorder caused by genetic mutations of specific coagulation plasma factors. It is a well-established predisposing factor for venous as well as arterial thromboembolism. Thromboembolic events with renal involvement in patients with inherited thrombophilia are possible but relatively rare. On the other hand, vascular complications, including renal artery and vein thrombosis, are the main causes of early graft loss after kidney transplantation. Furthermore, there is evidence that inherited thrombophilia has a role in chronic kidney disease development. Although there are data on kidney transplantation of recipients with inherited thrombophilia, to the best of our knowledge there are no reports on kidney donation from patients with thrombophilia in the English literature. We present 2 cases of successful kidney transplantation from the same donor with inherited thrombophilia.
    MeSH term(s) Blood Coagulation Factors ; Humans ; Kidney Transplantation/adverse effects ; Risk Factors ; Thromboembolism/etiology ; Thrombophilia/complications ; Thrombophilia/genetics ; Venous Thrombosis/etiology
    Chemical Substances Blood Coagulation Factors
    Language English
    Publishing date 2022-07-14
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 82046-5
    ISSN 1873-2623 ; 0041-1345
    ISSN (online) 1873-2623
    ISSN 0041-1345
    DOI 10.1016/j.transproceed.2022.03.053
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Kidney Transplantation in Patients With the History of SARS-CoV-2 Infection.

    Juric, Ivana / Katalinic, Lea / Furic-Cunko, Vesna / Basic-Jukic, Nikolina

    Transplantation proceedings

    2022  

    Abstract: Background: The aim of this study is to present the experience and results of kidney transplantation in patients with the history of SARS-CoV-2 infection.: Methods: We retrospectively analyzed waitlisted patients who had a history of SARS-CoV-2 ... ...

    Abstract Background: The aim of this study is to present the experience and results of kidney transplantation in patients with the history of SARS-CoV-2 infection.
    Methods: We retrospectively analyzed waitlisted patients who had a history of SARS-CoV-2 infection and offered a kidney transplant between March 2020 and December 2021.
    Results: Of the 97 waitlisted potential kidney transplant recipients who were offered a kidney, 13 (13.4%) had a history of SARS-CoV-2 infection. All patients were tested negative for SARS-CoV-2 at the time of the kidney offer. Successful transplantation was performed in 9 patients (5 male; average age was 40.8 years), with the average time between SARS-CoV-2 infection and transplantation of 8 months. Four of 13 patients with a history of SARS-CoV-2 infection were finally not transplanted, with 2 patients not eligible for transplantation due to significant post-COVID findings in routine pretransplant chest CT scans, and 2 patients were not transplanted because of poor donor organ quality.
    Conclusions: Kidney transplantation after SARS-CoV-2 infection is possible in a setting of full recovery from acute infection, negative PCR test, and no pneumonic infiltrates on chest CT scan. A growing number of waitlisted patients with a history of SARS-CoV-2 infection imposes the need for decision-making tools and guidelines for risk/benefit assessment in these patients.
    Language English
    Publishing date 2022-09-06
    Publishing country United States
    Document type Journal Article
    ZDB-ID 82046-5
    ISSN 1873-2623 ; 0041-1345
    ISSN (online) 1873-2623
    ISSN 0041-1345
    DOI 10.1016/j.transproceed.2022.08.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Regulation of mRNA Translation by Hormone Receptors in Breast and Prostate Cancer.

    Xie, Jianling / Kusnadi, Eric P / Furic, Luc / Selth, Luke A

    Cancers

    2021  Volume 13, Issue 13

    Abstract: Breast and prostate cancer are the second and third leading causes of death amongst all cancer types, respectively. Pathogenesis of these malignancies is characterised by dysregulation of sex hormone signalling pathways, mediated by the estrogen receptor- ...

    Abstract Breast and prostate cancer are the second and third leading causes of death amongst all cancer types, respectively. Pathogenesis of these malignancies is characterised by dysregulation of sex hormone signalling pathways, mediated by the estrogen receptor-α (ER) in breast cancer and androgen receptor (AR) in prostate cancer. ER and AR are transcription factors whose aberrant function drives oncogenic transcriptional programs to promote cancer growth and progression. While ER/AR are known to stimulate cell growth and survival by modulating gene transcription, emerging findings indicate that their effects in neoplasia are also mediated by dysregulation of protein synthesis (i.e., mRNA translation). This suggests that ER/AR can coordinately perturb both transcriptional and translational programs, resulting in the establishment of proteomes that promote malignancy. In this review, we will discuss relatively understudied aspects of ER and AR activity in regulating protein synthesis as well as the potential of targeting mRNA translation in breast and prostate cancer.
    Language English
    Publishing date 2021-06-29
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers13133254
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Myelodysplastic syndrome in a kidney transplant recipient after SARS-CoV-2 infection: can SARS-CoV-2 induce myelodysplastic syndrome?

    Juric, Ivana / Katalinic, Lea / Furic-Cunko, Vesna / Basic-Jukic, Nikolina

    International urology and nephrology

    2021  Volume 54, Issue 7, Page(s) 1775–1776

    MeSH term(s) COVID-19 ; Humans ; Kidney Transplantation/adverse effects ; Myelodysplastic Syndromes/complications ; Myelodysplastic Syndromes/therapy ; SARS-CoV-2 ; Transplant Recipients
    Language English
    Publishing date 2021-11-23
    Publishing country Netherlands
    Document type Letter ; Comment
    ZDB-ID 204048-7
    ISSN 1573-2584 ; 0301-1623 ; 0042-1162
    ISSN (online) 1573-2584
    ISSN 0301-1623 ; 0042-1162
    DOI 10.1007/s11255-021-03069-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Praćenje i liječenje bolesnika s transplantiranim bubregom tijekom COVID-19 pandemije ; Monitoring and Treatment of Renal Transplant Patients During the COVID-19 Pandemic

    Bašić-Jukić, Nikolina / Jurić, Ivana / Furić-Čunko, Vesna / Katalinić, Lea

    Medicus

    2020  

    Abstract: Pandemija COVID-19 paralizirala je transplantacijske programe širom svijeta, uz visoke stope smrtnosti u populaciji bolesnika s transplantiranim bubregom. Suočeni s nepoznatim patogenom svjedočimo čitavom nizu manje ili više uspješnih pokušaja liječenja. ...

    Abstract Pandemija COVID-19 paralizirala je transplantacijske programe širom svijeta, uz visoke stope smrtnosti u populaciji bolesnika s transplantiranim bubregom. Suočeni s nepoznatim patogenom svjedočimo čitavom nizu manje ili više uspješnih pokušaja liječenja. Bolesnici s transplantiranim bubregom su posebno ugrožena skupina s obzirom na kronično stanje imunosupresije. Dodatan problem u liječenju COVID-19 predstavlja problem mogućih interakcija lijekova koji se rabe u liječenju SARS-CoV-2 s imunosupresivima, kao i rizik akutnih odbacivanja prilikom značajnih smanjivanja imunosupresije. Ponovno oživljavanje transplantacijskih programa zahtijevat će pažljivu procjenu rizika i dobrobiti za svakoga pojedinog bolesnika uz promišljanje načina uspostave međunarodne razmjene organa. Potrebna su daljnja istraživanja kako bi se odredio optimalan način liječenja SARS-CoV-2 u bolesnika s transplantiranim bubregom.

    The COVID-19 pandemic has paralyzed renal transplant programs worldwide, with high mortality rates in renal transplant patients. Faced with an unknown pathogen, we have witnessed numerous treatment attempts that have been more or less effective. Renal transplant recipients are at increased risk for morbidity and mortality from COVID-19 given their chronic immunocompromised state. Additional complications are potential interactions in drugs used for treatment of SARS-CoV-2 and immunosuppressive medications, as well as risk of acute allograft rejection associated with reduction of immunosuppression. The revival of renal transplant programs will require careful assessment of individual risk-to-benefit ratio for each patient, with step-by-step reintroduction of international organ exchange. Further studies are needed to determine optimal treatment of SARS-CoV-2 in renal transplant recipients.
    Keywords transplantacija bubrega ; COVID-19 ; imunosupresija ; SARS-CoV-2 ; renal transplantation,;COVID-19 ; immunosuppression ; covid19
    Language Croatian
    Publisher PLIVA CROATIA d.o.o.
    Publishing country hr
    Document type Article ; Online
    ISSN 1848-8315
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article: Search for exclusive Z-boson production and observation of high-mass pp[over ]-->pgammagammap[over ]-->pl;{+}l;{-}p[over ] events in pp[over ] collisions at sqrt[s]=1.96 TeV.

    Aaltonen, T / Adelman, J / Akimoto, T / Albrow, M G / Alvarez González, B / Amerio, S / Amidei, D / Anastassov, A / Annovi, A / Antos, J / Apollinari, G / Apresyan, A / Arisawa, T / Artikov, A / Ashmanskas, W / Attal, A / Aurisano, A / Azfar, F / Badgett, W /
    Barbaro-Galtieri, A / Barnes, V E / Barnett, B A / Barria, P / Bartsch, V / Bauer, G / Beauchemin, P-H / Bedeschi, F / Beecher, D / Behari, S / Bellettini, G / Bellinger, J / Benjamin, D / Beretvas, A / Beringer, J / Bhatti, A / Binkley, M / Bisello, D / Bizjak, I / Blair, R E / Blocker, C / Blumenfeld, B / Bocci, A / Bodek, A / Boisvert, V / Bolla, G / Bortoletto, D / Boudreau, J / Boveia, A / Brau, B / Bridgeman, A / Brigliadori, L / Bromberg, C / Brubaker, E / Budagov, J / Budd, H S / Budd, S / Burke, S / Burkett, K / Busetto, G / Bussey, P / Buzatu, A / Byrum, K L / Cabrera, S / Calancha, C / Campanelli, M / Campbell, M / Canelli, F / Canepa, A / Carls, B / Carlsmith, D / Carosi, R / Carrillo, S / Carron, S / Casal, B / Casarsa, M / Castro, A / Catastini, P / Cauz, D / Cavaliere, V / Cavalli-Sforza, M / Cerri, A / Cerrito, L / Chang, S H / Chen, Y C / Chertok, M / Chiarelli, G / Chlachidze, G / Chlebana, F / Cho, K / Chokheli, D / Chou, J P / Choudalakis, G / Chuang, S H / Chung, K / Chung, W H / Chung, Y S / Chwalek, T / Ciobanu, C I / Ciocci, M A / Clark, A / Clark, D / Compostella, G / Convery, M E / Conway, J / Cordelli, M / Cortiana, G / Cox, C A / Cox, D J / Crescioli, F / Cuenca Almenar, C / Cuevas, J / Culbertson, R / Cully, J C / Dagenhart, D / Datta, M / Davies, T / de Barbaro, P / De Cecco, S / Deisher, A / De Lorenzo, G / Dell'orso, M / Deluca, C / Demortier, L / Deng, J / Deninno, M / Derwent, P F / Di Canto, A / di Giovanni, G P / Dionisi, C / Di Ruzza, B / Dittmann, J R / D'Onofrio, M / Donati, S / Dong, P / Donini, J / Dorigo, T / Dube, S / Efron, J / Elagin, A / Erbacher, R / Errede, D / Errede, S / Eusebi, R / Fang, H C / Farrington, S / Fedorko, W T / Feild, R G / Feindt, M / Fernandez, J P / Ferrazza, C / Field, R / Flanagan, G / Forrest, R / Frank, M J / Franklin, M / Freeman, J C / Furic, I / Gallinaro, M / Galyardt, J / Garberson, F / Garcia, J E / Garfinkel, A F / Garosi, P / Genser, K / Gerberich, H / Gerdes, D / Gessler, A / Giagu, S / Giakoumopoulou, V / Giannetti, P / Gibson, K / Gimmell, J L / Ginsburg, C M / Giokaris, N / Giordani, M / Giromini, P / Giunta, M / Giurgiu, G / Glagolev, V / Glenzinski, D / Gold, M / Goldschmidt, N / Golossanov, A / Gomez, G / Gomez-Ceballos, G / Goncharov, M / González, O / Gorelov, I / Goshaw, A T / Goulianos, K / Gresele, A / Grinstein, S / Grosso-Pilcher, C / Grundler, U / Guimaraes da Costa, J / Gunay-Unalan, Z / Haber, C / Hahn, K / Hahn, S R / Halkiadakis, E / Han, B-Y / Han, J Y / Happacher, F / Hara, K / Hare, D / Hare, M / Harper, S / Harr, R F / Harris, R M / Hartz, M / Hatakeyama, K / Hays, C / Heck, M / Heijboer, A / Heinrich, J / Henderson, C / Herndon, M / Heuser, J / Hewamanage, S / Hidas, D / Hill, C S / Hirschbuehl, D / Hocker, A / Hou, S / Houlden, M / Hsu, S-C / Huffman, B T / Hughes, R E / Husemann, U / Hussein, M / Huston, J / Incandela, J / Introzzi, G / Iori, M / Ivanov, A / James, E / Jang, D / Jayatilaka, B / Jeon, E J / Jha, M K / Jindariani, S / Johnson, W / Jones, M / Joo, K K / Jun, S Y / Jung, J E / Junk, T R / Kamon, T / Kar, D / Karchin, P E / Kato, Y / Kephart, R / Ketchum, W / Keung, J / Khotilovich, V / Kilminster, B / Kim, D H / Kim, H S / Kim, H W / Kim, J E / Kim, M J / Kim, S B / Kim, S H / Kim, Y K / Kimura, N / Kirsch, L / Klimenko, S / Knuteson, B / Ko, B R / Kondo, K / Kong, D J / Konigsberg, J / Korytov, A / Kotwal, A V / Kreps, M / Kroll, J / Krop, D / Krumnack, N / Kruse, M / Krutelyov, V / Kubo, T / Kuhr, T / Kulkarni, N P / Kurata, M / Kwang, S / Laasanen, A T / Lami, S / Lammel, S / Lancaster, M / Lander, R L / Lannon, K / Lath, A / Latino, G / Lazzizzera, I / Lecompte, T / Lee, E / Lee, H S / Lee, S W / Leone, S / Lewis, J D / Lin, C-S / Linacre, J / Lindgren, M / Lipeles, E / Lister, A / Litvintsev, D O / Liu, C / Liu, T / Lockyer, N S / Loginov, A / Loreti, M / Lovas, L / Lucchesi, D / Luci, C / Lueck, J / Lujan, P / Lukens, P / Lungu, G / Lyons, L / Lys, J / Lysak, R / Macqueen, D / Madrak, R / Maeshima, K / Makhoul, K / Maki, T / Maksimovic, P / Malde, S / Malik, S / Manca, G / Manousakis-Katsikakis, A / Margaroli, F / Marino, C / Marino, C P / Martin, A / Martin, V / Martínez, M / Martínez-Ballarín, R / Maruyama, T / Mastrandrea, P / Masubuchi, T / Mathis, M / Mattson, M E / Mazzanti, P / McFarland, K S / McIntyre, P / McNulty, R / Mehta, A / Mehtala, P / Menzione, A / Merkel, P / Mesropian, C / Miao, T / Miladinovic, N / Miller, R / Mills, C / Milnik, M / Mitra, A / Mitselmakher, G / Miyake, H / Moggi, N / Moon, C S / Moore, R / Morello, M J / Morlock, J / Movilla Fernandez, P / Mülmenstädt, J / Mukherjee, A / Muller, Th / Mumford, R / Murat, P / Mussini, M / Nachtman, J / Nagai, Y / Nagano, A / Naganoma, J / Nakamura, K / Nakano, I / Napier, A / Necula, V / Nett, J / Neu, C / Neubauer, M S / Neubauer, S / Nielsen, J / Nodulman, L / Norman, M / Norniella, O / Nurse, E / Oakes, L / Oh, S H / Oh, Y D / Oksuzian, I / Okusawa, T / Orava, R / Osterberg, K / Pagan Griso, S / Palencia, E / Papadimitriou, V / Papaikonomou, A / Paramonov, A A / Parks, B / Pashapour, S / Patrick, J / Pauletta, G / Paulini, M / Paus, C / Peiffer, T / Pellett, D E / Penzo, A / Phillips, T J / Piacentino, G / Pianori, E / Pinera, L / Pinfold, J / Pitts, K / Plager, C / Pondrom, L / Poukhov, O / Pounder, N / Prakoshyn, F / Pronko, A / Proudfoot, J / Ptohos, F / Pueschel, E / Punzi, G / Pursley, J / Rademacker, J / Rahaman, A / Ramakrishnan, V / Ranjan, N / Redondo, I / Renton, P / Renz, M / Rescigno, M / Richter, S / Rimondi, F / Ristori, L / Robson, A / Rodrigo, T / Rodriguez, T / Rogers, E / Rolli, S / Roser, R / Rossi, M / Rossin, R / Roy, P / Ruiz, A / Russ, J / Rusu, V / Rutherford, B / Saarikko, H / Safonov, A / Sakumoto, W K / Saltó, O / Santi, L / Sarkar, S / Sartori, L / Sato, K / Savoy-Navarro, A / Schlabach, P / Schmidt, A / Schmidt, E E / Schmidt, M A / Schmidt, M P / Schmitt, M / Schwarz, T / Scodellaro, L / Scribano, A / Scuri, F / Sedov, A / Seidel, S / Seiya, Y / Semenov, A / Sexton-Kennedy, L / Sforza, F / Sfyrla, A / Shalhout, S Z / Shears, T / Shepard, P F / Shimojima, M / Shiraishi, S / Shochet, M / Shon, Y / Shreyber, I / Sinervo, P / Sisakyan, A / Slaughter, A J / Slaunwhite, J / Sliwa, K / Smith, J R / Snider, F D / Snihur, R / Soha, A / Somalwar, S / Sorin, V / Spalding, J / Spreitzer, T / Squillacioti, P / Stanitzki, M / St Denis, R / Stelzer, B / Stelzer-Chilton, O / Stentz, D / Strologas, J / Strycker, G L / Stuart, D / Suh, J S / Sukhanov, A / Suslov, I / Suzuki, T / Taffard, A / Takashima, R / Takeuchi, Y / Tanaka, R / Tecchio, M / Teng, P K / Terashi, K / Thom, J / Thompson, A S / Thompson, G A / Thomson, E / Tipton, P / Ttito-Guzmán, P / Tkaczyk, S / Toback, D / Tokar, S / Tollefson, K / Tomura, T / Tonelli, D / Torre, S / Torretta, D / Totaro, P / Tourneur, S / Trovato, M / Tsai, S-Y / Tu, Y / Turini, N / Ukegawa, F / Vallecorsa, S / van Remortel, N / Varganov, A / Vataga, E / Vázquez, F / Velev, G / Vellidis, C / Vidal, M / Vidal, R / Vila, I / Vilar, R / Vine, T / Vogel, M / Volobouev, I / Volpi, G / Wagner, P / Wagner, R G / Wagner, R L / Wagner, W / Wagner-Kuhr, J / Wakisaka, T / Wallny, R / Wang, S M / Warburton, A / Waters, D / Weinberger, M / Weinelt, J / Wester, W C / Whitehouse, B / Whiteson, D / Wicklund, A B / Wicklund, E / Wilbur, S / Williams, G / Williams, H H / Wilson, P / Winer, B L / Wittich, P / Wolbers, S / Wolfe, C / Wright, T / Wu, X / Würthwein, F / Xie, S / Yagil, A / Yamamoto, K / Yamaoka, J / Yang, U K / Yang, Y C / Yao, W M / Yeh, G P / Yoh, J / Yorita, K / Yoshida, T / Yu, G B / Yu, I / Yu, S S / Yun, J C / Zanello, L / Zanetti, A / Zhang, L / Zhang, X / Zheng, Y / Zucchelli, S

    Physical review letters

    2009  Volume 102, Issue 22, Page(s) 222002

    Abstract: ... at sqrt[s]=1.96 TeV, using the CDF II detector. No exclusive Z-->l;{+}l;{-} candidates are observed and ... from the process pp[over ]-->pgammagammap[over ]-->pl;{+}l;{-}p[over ] are observed, and a measurement of the cross ... section for M_{ll}>40 GeV/c;{2} and |eta_{l}|<4 is found to be sigma=0.24_{-0.10};{+0.13} pb, which is ...

    Abstract This Letter presents a search for exclusive Z boson production in proton-antiproton collisions at sqrt[s]=1.96 TeV, using the CDF II detector. No exclusive Z-->l;{+}l;{-} candidates are observed and the first upper limit on the exclusive Z cross section in hadron collisions is found to be sigma_{excl}(Z)<0.96 pb at 95% confidence level. In addition, eight candidate exclusive dilepton events from the process pp[over ]-->pgammagammap[over ]-->pl;{+}l;{-}p[over ] are observed, and a measurement of the cross section for M_{ll}>40 GeV/c;{2} and |eta_{l}|<4 is found to be sigma=0.24_{-0.10};{+0.13} pb, which is consistent with the standard model prediction.
    Language English
    Publishing date 2009-06-05
    Publishing country United States
    Document type Journal Article
    ZDB-ID 208853-8
    ISSN 1079-7114 ; 0031-9007
    ISSN (online) 1079-7114
    ISSN 0031-9007
    DOI 10.1103/PhysRevLett.102.222002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top